ALMR

Alamar Biosciences, Inc. - Class A common stock (ALMR)

About Alamar Biosciences, Inc. - Class A common stock (ALMR)

Alamar Biosciences, Inc. engages in developing a proteomic liquid biopsy platform and sells instruments, consumables & services for the early detection of diseases. Its products include ARGO HT system, NULISA assays for Immunology, neurology & oncology, NULISAqpcr custom assay development, technology access program and Alamar analysis solutions. The company was founded by Yuling Luo, Yiyuan Yin and Steve Chen in May 2018 and is headquartered in Fremont, CA.

Details

Daily high

$35.34

Daily low

$32.00

Price at open

$32.13

52 Week High

$38.54

52 Week Low

$17.00

Market cap

2.2B

Dividend yield

Volume

355,451

Avg. volume

294,389

P/E ratio

Alamar Biosciences, Inc. - Class A common stock News